Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients

• Verfasst von: Höcker, Britta [VerfasserIn]
• Verfasst von: Fickenscher, Helmut [VerfasserIn]
• Verfasst von: Delecluse, Henri-Jacques [VerfasserIn]
• Verfasst von: Böhm, Stephan [VerfasserIn]
• Verfasst von: Küsters, Uta [VerfasserIn]
• Verfasst von: Schnitzler, Paul [VerfasserIn]
• Verfasst von: Pohl, Martin [VerfasserIn]
• Verfasst von: John, Ulrike [VerfasserIn]
• Verfasst von: Kemper, Markus J. [VerfasserIn]
• Verfasst von: Fehrenbach, Henry [VerfasserIn]
• Verfasst von: Wigger, Marianne [VerfasserIn]
• Verfasst von: Holder, Martin [VerfasserIn]
• Verfasst von: Schröder, Monika [VerfasserIn]
• Verfasst von: Billing, Heiko [VerfasserIn]
• Verfasst von: Fichtner, Alexander [VerfasserIn]
• Verfasst von: Feneberg, Reinhard [VerfasserIn]
• Verfasst von: Sander, Anja [VerfasserIn]
• Verfasst von: Köpf-Shakib, Sabine [VerfasserIn]
• Verfasst von: Süsal, Caner [VerfasserIn]
• Verfasst von: Tönshoff, Burkhard [VerfasserIn]
• Titel: Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients
• Titelzusatz: a multicenter, prospective study
• Verf.angabe: Britta Höcker, Helmut Fickenscher, Henri-Jacques Delecluse, Stephan Böhm, Uta Küsters, Paul Schnitzler, Martin Pohl, Ulrike John, Markus J. Kemper, Henry Fehrenbach, Marianne Wigger, Martin Holder, Monika Schröder, Heiko Billing, Alexander Fichtner, Reinhard Feneberg, Anja Sander, Sabine Köpf-Shakib, Caner Süsal, and Burkhard Tönshoff
• Jahr: 2013
• Umfang: 9 S.
• Fussnoten: Published: 05 October 2012 ; Gesehen am 12.07.2018
• Titel Quelle: Enthalten in: Clinical infectious diseases
• Ort Quelle: Oxford : Oxford Journals, 1992
• Jahr Quelle: 2013
• Band/Heft Quelle: 56(2013), 1, Seite 84-92
• ISSN Quelle: 1537-6591
• DOI: doi:10.1093/cid/cis823
• Datenträger: Online-Ressource
• Sprache: eng
• Bibliogr. Hinweis: Erscheint auch als : Druck-Ausgabe: Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients. - 2013
• K10plus-PPN: 157755860X

Abstract

Background: The epidemiology and morbidity of Epstein-Barr virus (EBV) infection in pediatric renal transplant recipients have been characterized insufficiently. Methods: In a prospective, multicenter study among 106 pediatric kidney allograft recipients aged 11.4 ± 5.9 years, we investigated the epidemiology of EBV infection and the relationship between EBV load, EBV serology, and EBV-related morbidity (posttransplant lymphoproliferative disease [PTLD] or symptomatic EBV infection, defined as flu-like symptoms or infectious mononucleosis). Results: EBV primary infection occurred in 27 of 43 (63%) seronegative patients and reactivation/reinfection in 28 of 63 (44%) seropositive patients. There was no association between the degree or duration of EBV load and EBV-related morbidity: The vast majority (17 of 18 [94%]) of patients with a high, persistent EBV load remained PTLD-free throughout a follow-up of 5.0 ± 1.3 years, while 2 of 3 (66%) patients with EBV-related PTLD exhibited only a low EBV load beforehand. Eight of 18 (44%) patients with a high, persistent EBV load remained asymptomatic during a follow-up of 5.3 ± 2.9 years. Multivariate analysis identified the EBV high-risk (D+/R–) serostatus (odds ratio [OR], 7.07; P < .05), the presence of human leukocyte antigen (HLA)–DR7 (OR, 5.65; P < .05), and the intensity of the immunosuppressive therapy (OR, 1.53; P < .01) as independent risk factors for the development of a symptomatic EBV infection. Conclusions: Presence of EBV high-risk seroconstellation, HLA-DR7, and intensity of immunosuppressive therapy are significant risk factors for a symptomatic EBV infection, whereas there is no close association between the degree or duration of EBV load and EBV-related morbidity.